title: [Fabry disease--guidelines for diagnosis and management of adult patients].
abstract: Early diagnosis and management of patients with Fabry disease (FD) requires a multidisciplinary approach of several different experts. The aim of this document is to provide health care professionals with guidelines for management of adult patients with Fabry disease. These guidelines were produced by the staff of the Division of Metabolic Diseases, Department of Internal Medicine, University Hospital Center Zagreb, which is the Referral Expert Center for Rare and Metabolic Diseases of the Ministry of Health, Republic of Croatia. The first guidelines ever published in Croatia concerning a rare metabolic disease are presented. This document provides a short summary on Fabry disease, how to diagnose Fabry disease, management of patients with this disease, follow-up of the patients, and gives recommendations on therapy and genetic testing.
authors.forename: Marijan
authors.initials: M
authors.lastname: Merkler
authors.forename: Ivan
authors.initials: I
authors.lastname: Pećin
authors.forename: Iveta
authors.initials: I
authors.lastname: Simić
authors.forename: Diana
authors.initials: D
authors.lastname: Muacević-Katanec
authors.forename: Nediljko
authors.initials: N
authors.lastname: Sućur
authors.forename: Zeljko
authors.initials: Z
authors.lastname: Reiner
mesh_terms: D000328:Adult; D017523:Croatia; D000795:Fabry Disease / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy*; D005817:Genetic Counseling / Q000379:methods*; D005820:Genetic Testing; D006801:Humans; D007400:Interprofessional Relations; D007527:Isoenzymes / Q000627:therapeutic use; D008017:Life Expectancy; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D012955:Societies, Medical / Q000592:standards; D000519:alpha-Galactosidase / Q000627:therapeutic use
chemical_list: D007527:Isoenzymes; D000519:alpha-Galactosidase